Physician profile
Anthony C Bui
NPI 1598325805
$55,124.36
in general payments reported to CMS, 2019-2025
15 companies · $586 in 2025
The $586 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2021: $77.75 · 2022: $144 · 2023: $2,926 · 2024: $51K · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Food and Beverage: $3,489 · Travel and Lodging: $1,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Food and Beverage | $3,489.47 |
| Travel and Lodging | $1,310.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $52,837.25 | 2019-2025 | Ams 700, General - Erectile Dysfunction, Lithovue |
| Coloplast Corp | $1,260.13 | 2023-2025 | Titan, Speedicath |
| Pfizer INC. | $199.88 | 2021-2024 | |
| Biotissue Holdings INC. | $152.91 | 2023 | |
| Olympus America INC. | $145.56 | 2025 | Gyrus Acmi, Soltive |
| Endo USA, INC. | $125.37 | 2024 | Xiaflex |
| Myriad Genetic Laboratories, INC. | $95.27 | 2023 | Prolaris |
| Merck Sharp & Dohme LLC | $62.94 | 2021-2023 | Lynparza, Keytruda |
| 180 Medical, INC. | $53.19 | 2024 | Gentlecath |
| Antares Pharma, INC. | $50.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $45.17 | 2024 | |
| Blue Earth Diagnostics | $29.84 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $24.65 | 2021 | |
| Astellas Pharma US INC | $23.92 | 2023 | Xtandi |
| Abbvie INC. | $18.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.